Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 08.03.2021 1 Am J Hum Genet 2 Ann Surg Oncol 2 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 6 Br J Surg 1 Cancer Res 2 Clin Res Hepatol Gastroenterol 1 Dis Colon Rectum 1 Eur J Cancer 9 Eur J Surg Oncol 1 Gut 1 Int J Colorectal Dis 1 J Clin Oncol 3 J Surg Oncol 6 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hum Genet

1. LI S, Hopper JL
   Age dependency of the polygenic risk score for colorectal cancer.
   Am J Hum Genet. 2021;108:525-526.
   PubMed        
   
   

   
   Ann Surg Oncol

2. PEACOCK O, Chang GJ
   The Landmark Series: Management of Lateral Lymph Nodes in Locally Advanced Rectal Cancer.
   Ann Surg Oncol. 2020;27:2723-2731.
   PubMed         Abstract available
   
   
3. STERPETTI AV, Costi U, Grande R, D'Ermo G, et al
   De Novo Secondary Adenocarcinoma in the Colon Used as Urinary Diversion Not in Contact with the Fecal Stream: Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2020;27:2750-2759.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. LIN PC, Yeh YM, Chan RH, Lin BW, et al
   Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
   BMC Cancer. 2021;21:217.
   PubMed         Abstract available
   
   
5. FONSECA AS, Ramao A, Burger MC, de Souza JES, et al
   ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
   BMC Cancer. 2021;21:207.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. LIU Z, Xu Y, Xu G, Baklaushev VP, et al
   Nomogram for predicting overall survival in colorectal cancer with distant metastasis.
   BMC Gastroenterol. 2021;21:103.
   PubMed         Abstract available
   
   

   
   Br J Cancer

7. YAEGASHI M, Iwaya T, Sasaki N, Fujita M, et al
   Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling.
   Br J Cancer. 2021 Mar 3. pii: 10.1038/s41416-021-01266.
   PubMed         Abstract available
   
   

   
   Br J Surg

8. WILLIAMSON JS, Quyn AJ, Sagar PM
   Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management.
   Br J Surg. 2020;107:1562-1569.
   PubMed         Abstract available
   
   
9. EFETOV SK, Lychagin AV, Zubayraeva AA, Picciariello A, et al
   3D-printed pubic bone for pelvic ring reconstruction after exenteration for anal cancer recurrence.
   Br J Surg. 2020;107:e512-e514.
   PubMed        
   
   
10. ZHOU X, Liu Z, Zhang D, Wu L, et al
    Improving initial nodal staging of T3 rectal cancer using quantitative image features.
    Br J Surg. 2020;107:e541-e542.
    PubMed        
    
    
11. PEACOCK O, Limvorapitak T, Hu CY, Bednarski BK, et al
    Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes.
    Br J Surg. 2020;107:1552-1557.
    PubMed         Abstract available
    
    
12. CAHILL RA, O'Shea DF, Khan MF, Khokhar HA, et al
    Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification.
    Br J Surg. 2021;108:5-9.
    PubMed        
    
    
13. HABIB BEDWANI N, English W, Coda S, Akinlade F, et al
    Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Br J Surg. 2021;108:e18-e19.
    PubMed        
    
    

    
    Cancer Res

14. BARNOUD T, Leung JC, Leu JI, Basu S, et al
    A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in Tumors.
    Cancer Res. 2020;80:5270-5281.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

15. GALLOIS C, Bourillon C, Auclin E, Artru P, et al
    Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.
    Clin Res Hepatol Gastroenterol. 2021;45:101603.
    PubMed         Abstract available
    
    
16. LI L, Cui N, Hao T, Zou J, et al
    Statins use and the prognosis of colorectal cancer: a meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021;45:101588.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

17. WATANABE J, Ishibe A, Ohya H, Suwa Y, et al
    Evaluating the Effect of Intraoperative Near-Infrared Observation on Anastomotic Leakage after Stapled Side-To-Side Anastomosis in Colon Cancer Surgery Using Propensity Score-Matching.
    Dis Colon Rectum. 2021 Mar 2. pii: 00003453-900000000-99560.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

18. HEINRICH K, Modest DP, Ricard I, Fischer von Weikersthal L, et al
    Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).
    Eur J Cancer. 2021;147:128-139.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

19. GAO Z, Zhang D, Lei F, Zeng Q, et al
    Surgical treatment of massive stoma site tumors after a curative operation for rectal cancer.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available
    
    
20. CHANG W, Liu T, Ren L, He G, et al
    A trinity technique for prevention of low rectal anastomotic leakage in the robotic era.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available
    
    
21. JONES HJS, Al-Najami I, Cunningham C
    Quality of life after rectal-preserving treatment of rectal cancer.
    Eur J Surg Oncol. 2020;46:2050-2056.
    PubMed         Abstract available
    
    
22. REN C, Xu RH
    The drug treatment research of gastrointestinal cancer in China.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available
    
    
23. ZHANG Z, Cheng S, Gong J, Lu M, et al
    Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available
    
    
24. ZHENG Z, Wang X, Huang Y, Lu X, et al
    Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Eur J Surg Oncol. 2020;46:2057-2063.
    PubMed         Abstract available
    
    
25. STERPETTI AV, Sapienza P, Fiori E, Marzo LD, et al
    Improved results for left-sided malignant colorectal obstruction with a proper selection for self expandable metal stent placement, surgical resection or diverting stoma.
    Eur J Surg Oncol. 2020;46:2064-2067.
    PubMed         Abstract available
    
    
26. GUAN X, Lu Z, Wang S, Liu E, et al
    Comparative short- and long-term outcomes of three techniques of natural orifice specimen extraction surgery for rectal cancer.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available
    
    
27. BIRGISSON H, Enblad M, Artursson S, Ghanipour L, et al
    Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2020;46:2283-2291.
    PubMed         Abstract available
    
    

    
    Gut

28. CROSS AJ, Robbins EC, Pack K, Stenson I, et al
    Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines.
    Gut. 2021 Mar 5. pii: gutjnl-2020-323411. doi: 10.1136/gutjnl-2020-323411.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

29. STRATMANN K, Czerwinska K, Filmann N, Tacke W, et al
    Prevalence of colorectal cancer and its precursor lesions in symptomatic patients under 55 years of age undergoing total colonoscopy: results of a large retrospective, multicenter, controlled endoscopy study.
    Int J Colorectal Dis. 2021 Mar 5. pii: 10.1007/s00384-021-03898.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

30. TANG W, Ren L, Liu T, Ye Q, et al
    Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial.
    J Clin Oncol. 2020;38:3175-3184.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

31. MURPHY C, Stephens I, OFlanagan G, OByrne L, et al
    A comparison of oncological outcomes after abdominoperineal excision before and after the implementation of a selective perineal flap closure program.
    J Surg Oncol. 2021;123:614-621.
    PubMed         Abstract available
    
    
32. GIESEN LJX, Borstlap WAA, Bemelman WA, Tanis PJ, et al
    Effect of understaging on local recurrence of rectal cancer.
    J Surg Oncol. 2020;122:1179-1186.
    PubMed         Abstract available
    
    
33. SUN Y, Zhang D, Feng Y, Wang Y, et al
    Infrapyloric lymph node dissection in right hemicolectomy for colon cancer: Should prophylactic resection be recommended?
    J Surg Oncol. 2021 Mar 1. doi: 10.1002/jso.26388.
    PubMed         Abstract available
    
    

    
    Oncol Rep

34. WANG X, Song Z, Hu B, Chen Z, et al
    MicroRNA642a5p inhibits colon cancer cell migration and invasion by targeting collagen type I alpha1.
    Oncol Rep. 2021;45:933-944.
    PubMed         Abstract available
    
    
35. ZHANG P, Yuan X, Yu T, Huang H, et al
    Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways.
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available
    
    
36. SUETSUGU T, Mori R, Futamura M, Fukada M, et al
    Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Oncol Rep. 2021;45:1-8.
    PubMed         Abstract available
    
    
37. POTURNAJOVA M, Furielova T, Balintova S, Schmidtova S, et al
    Molecular features and gene expression signature of metastatic colorectal cancer (Review).
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available
    
    
38. PARK SY, Kim JT, Park ES, Hwang YS, et al
    Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calciummediated cell signaling.
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available
    
    
39. VERDINA A, Di Segni M, Amoreo CA, Sperduti I, et al
    HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Oncol Rep. 2021;45:899-910.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: